Delivering the future of IMMUNOLOGY
Shaperon is a clinical stage biotech company developing Novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and Nanobody therapeutics
Inflammasomes are intracellular multiprotein complex in the innate immune system, the body’s first line of defense against PAMPs or host-derived cellular stress known as DAMPs. Once activated, inflammasomes produce highly proinflammatory cytokines and induce programmed cell death called pyroptosis. Dysregulation of inflammasomes is associated with a vast number of autoimmune and inflammatory disorders.
Nanobody is a single domain antibody that is the variable domain of heavy chain only antibody. It is naturally in the serum of camelidae (Camelid, Lama, Alpaca etc)
저희 회사의 파이프라인에 대해 궁금하시거나, 비즈니스 제휴를 희망하시는 개인, 기업은 아래 내용을 등록해 주시면 연락 드리도록 하겠습니다.